ArticleOncology letters2024

Successful treatment with trastuzumab plus chemotherapy as the first‑line regimen in advanced small bowel adenocarcinoma harboring HER2 amplification: A report of two cases.

Jingwen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.